Last update 01 Nov 2024
Nicotine/Opipramol
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Opipramol/nicotine |
Mechanism 5-HT2 receptor antagonists(Serotonin 2 (5-HT2) receptor antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists), H1 receptor antagonists(Histamine H1 receptor antagonists) + [5] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC23H30ClN3O |
InChIKeySFJIJRHAHHTWJO-UHFFFAOYSA-N |
CAS Registry909-39-7 |
View All Structures (2)
Related
1
Clinical Trials associated with Nicotine/OpipramolA Multicenter, Open Label, Escalating Dose Study to Assess the Tolerability and the Safety and to Explore the Efficacy and the Pharmacokinetics of ND0801 in Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)
100 Clinical Results associated with Nicotine/Opipramol
Login to view more data
100 Translational Medicine associated with Nicotine/Opipramol
Login to view more data
100 Patents (Medical) associated with Nicotine/Opipramol
Login to view more data
100 Deals associated with Nicotine/Opipramol
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Attention Deficit Disorder With Hyperactivity | Phase 2 | - | - | |
| Attention Deficit Disorder With Hyperactivity | Phase 2 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free